Proteome-wide Mendelian randomization identifies drug targets for atrial fibrillation/flutter
Abstract Background Developing effective and safe drug targets for atrial fibrillation/flutter (AF/AFL) is a critical clinical need. As the plasma proteome represents a major source of druggable targets, this study aimed to identify causal protein targets for AF/AFL and assess their potential side e...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2025-11-01
|
| Cyfres: | BMC Cardiovascular Disorders |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s12872-025-05383-3 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|